Sign in
CompletedNo phase

LED Low-Intensity Red Light for Myopia Control in Youth: Efficacy and Safety Study

Key facts

Who runs it
Shanghai Eye Disease Prevention and Treatment Center
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
40 people enrolled
Started
16 Apr 2025
Ended
31 Dec 2025
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Red light treatment with 1.6mW LED light source
  • Red light treatment with 0.001mW LED light source
Record updated
29 January 2026

Who can take part

Age
8 years to 12 years
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (13)Hide the full registry criteria

Who can take part

  • Age: 8-12 years old
  • Simple myopia: equivalent spherical lens ≤ -0.5D and > -6.0D after any cycloplegia, astigmatism ≤ 2.5D, anisometropia ≤ 1.5D
  • The best corrected visual acuity in one eye is 0.8 and above
  • Normal fundus, or only leopard-shaped fundus
  • Sign informed consent and be able to participate in the study

Who cannot take part

  • refractive media opacity: corneal opacity, cataract or intraocular lens surgery
  • The subject has other congenital eye diseases, such as congenital cataract, congenital glaucoma, etc
  • There are eye diseases that affect retinal function
  • There are other systemic disease abnormalities
  • Rule out hereditary myopia
  • Presence of strabismus or other binocular vision abnormalities
  • Children who had used or were using orthokeratology, atropine and other myopia control measures could be enrolled after stopping treatment for three months
  • Other reasons that the research doctor considers unsuitable for inclusion in the project

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this clinical trial was to investigate the efficacy and safety of repetitive low-intensity single-wavelength red light from an LED light source in controlling myopia progression in children and adolescents.

The 2 groups in the trial

  • LED Red light: 1.6 mW/twice dailyTreatment being tested

    Treatment: Red light treatment with 1.6mW LED light source

  • LED Red light: 0.001 mW/twice dailySham treatment, for comparison

    Treatment: Red light treatment with 0.001mW LED light source

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Exploratory Study on the Efficacy and Safety of LED Low-Intensity Red Light for Controlling Myopia Progression in Children and Adolescents
Publications
Record updated
29 January 2026